Anika Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
Anika Therapeutics, Inc. (ANIK) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $1.50 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-04.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2024-11-04
- Anika Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, amount for the quarter ending 2024-09-30 was $1.50M.
- Anika Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, amount for the quarter ending 2024-06-30 was $600.00K.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 3 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 6 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 9 month |
|---|---|---|---|
| 2024-09-30 | $1.50M 10-Q · filed 2024-11-04 | $2.10M derived: sum of 2 quarters · filed 2024-11-04 | $1.50M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $600.00K 10-Q · filed 2024-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |